• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液中Aβ和磷酸化tau181水平不一致时的可溶性触发受体表达量2(sTREM2)

sTREM2 in discordant CSF Aβ and p-tau181.

作者信息

Li Danni, Mantyh William G, Men Lu, Jain Ishika, Glittenberg Matthew, An Binchong, Zhang Lin, Li Ling

机构信息

Department of Lab Medicine and Pathology University of Minnesota Minneapolis USA.

Department of Neurology University of Minnesota Minneapolis USA.

出版信息

Alzheimers Dement (Amst). 2025 Jan 16;17(1):e70072. doi: 10.1002/dad2.70072. eCollection 2025 Jan-Mar.

DOI:10.1002/dad2.70072
PMID:39822286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11736621/
Abstract

INTRODUCTION

Little is known about the factors underpinning discordant cerebrospinal fluid (CSF) amyloid beta (Aβ) versus p-tau181/Aβ or CSF Aβ versus Aβ positron emission tomography (PET).

METHODS

We stratified 570 non-demented Alzheimer's Disease Neuroimaging Initiative (ADNI) participants by Aβ PET and further by CSF Aβ or p-tau181/Aβ. We used analysis of covariance testing adjusting for covariates, followed by Tukey post hoc pairwise comparisons, to compare CSF soluble triggering receptor expressed on myeloid cells-2 (sTREM2) across four participant groups: CSF+ with CSF- , CSF- with CSF+ , and concordant CSF/CSF. We also compared sTREM2 across discordant and concordant CSF/PET.

RESULTS

Regardless of Aβ PET status, CSF+ with CSF- had lower sTREM2 than CSF- with CSF+. CSF sTREM2 was similarly also associated with discordant CSF Aβ42 /PET.

DISCUSSION

Our study suggests the potential roles of sTREM2 in discordant CSF Aβ and p-tau181/Aβ and discordant CSF/PET. Low- and high-CSF sTREM2 may affect the accuracy of p-tau181/Aβ during the clinical work-up of AD.

HIGHLIGHTS

17% of non-demented older adults had discordant CSF Aβ versus p-tau181/Aβ.sTREM2 differed between discordant cases of CSF Aβ versus p-tau181/Aβ.20% of non-demented older adults had discordant CSF Aβ versus Aβ PET.sTREM2 also differed between discordant cases of CSF Aβ versus Aβ PET.p-tau181/Aβ may miss 6.7% of PET+ non-demented older adults with low sTREM2.

摘要

引言

关于导致脑脊液(CSF)淀粉样蛋白β(Aβ)与磷酸化tau181/Aβ不一致,或CSF Aβ与Aβ正电子发射断层扫描(PET)不一致的因素,我们了解甚少。

方法

我们根据Aβ PET对570名非痴呆的阿尔茨海默病神经影像学计划(ADNI)参与者进行分层,并进一步根据CSF Aβ或磷酸化tau181/Aβ进行分层。我们使用协方差分析并对协变量进行调整,随后进行Tukey事后成对比较,以比较四个参与者组之间的脑脊液髓样细胞上表达的可溶性触发受体2(sTREM2):CSF+与CSF-、CSF-与CSF+,以及一致的CSF/CSF。我们还比较了不一致和一致的CSF/PET之间的sTREM2。

结果

无论Aβ PET状态如何,CSF+与CSF-相比,sTREM2水平更低。CSF sTREM2同样也与不一致的CSF Aβ42/PET相关。

讨论

我们的研究表明sTREM2在不一致的CSF Aβ和磷酸化tau181/Aβ以及不一致的CSF/PET中可能发挥的作用。CSF sTREM2水平的高低可能会影响AD临床检查中磷酸化tau181/Aβ的准确性。

要点

17%的非痴呆老年人CSF Aβ与磷酸化tau181/Aβ不一致。CSF Aβ与磷酸化tau181/Aβ不一致的病例中sTREM2存在差异。20%的非痴呆老年人CSF Aβ与Aβ PET不一致。CSF Aβ与Aβ PET不一致的病例中sTREM2也存在差异。磷酸化tau181/Aβ可能会遗漏6.7%的PET+且sTREM2水平低的非痴呆老年人。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b9/11736621/975eee62c01e/DAD2-17-e70072-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b9/11736621/982c3f6e4ca8/DAD2-17-e70072-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b9/11736621/31154fc1a64e/DAD2-17-e70072-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b9/11736621/975eee62c01e/DAD2-17-e70072-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b9/11736621/982c3f6e4ca8/DAD2-17-e70072-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b9/11736621/31154fc1a64e/DAD2-17-e70072-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95b9/11736621/975eee62c01e/DAD2-17-e70072-g002.jpg

相似文献

1
sTREM2 in discordant CSF Aβ and p-tau181.脑脊液中Aβ和磷酸化tau181水平不一致时的可溶性触发受体表达量2(sTREM2)
Alzheimers Dement (Amst). 2025 Jan 16;17(1):e70072. doi: 10.1002/dad2.70072. eCollection 2025 Jan-Mar.
2
Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.小胶质细胞激活、tau病理改变及神经退行性变生物标志物可预测阿尔茨海默病连续体中的纵向认知衰退。
Front Aging Neurosci. 2022 Jun 30;14:848180. doi: 10.3389/fnagi.2022.848180. eCollection 2022.
3
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer's disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study.阿尔茨海默病患者脑脊液中淀粉样蛋白-β 42、淀粉样蛋白-β 40 与淀粉样蛋白-β 42/40 与可溶性磷酸化 tau 及疾病负担的相关性不同:一项脑脊液与氟代脱氧葡萄糖正电子发射断层扫描研究。
Alzheimers Res Ther. 2023 Aug 30;15(1):144. doi: 10.1186/s13195-023-01291-w.
4
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer's disease: a longitudinal study.阿尔茨海默病的神经影像学生物标志物和 CSF sTREM2 水平:一项纵向研究。
Sci Rep. 2024 Jul 3;14(1):15318. doi: 10.1038/s41598-024-66211-w.
5
Characterization of Alzheimer's tau biomarker discordance using plasma, CSF, and PET.利用血浆、脑脊液和 PET 对阿尔茨海默病 tau 生物标志物的不相符进行特征描述。
Alzheimers Res Ther. 2021 May 4;13(1):93. doi: 10.1186/s13195-021-00834-3.
6
Robustness of CSF Aβ42/40 and Aβ42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes.使用全自动免疫分析法测量 CSF Aβ42/40 和 Aβ42/P-tau181 的稳健性,以检测与 AD 相关的结果。
Alzheimers Dement. 2023 Jul;19(7):2994-3004. doi: 10.1002/alz.12897. Epub 2023 Jan 21.
7
Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.老年认知正常人群中β-淀粉样蛋白、小胶质细胞激活、皮质厚度与代谢的相关性研究
Neurology. 2024 Apr 9;102(7):e209205. doi: 10.1212/WNL.0000000000209205. Epub 2024 Mar 15.
8
Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.中国痴呆人群中脑脊液核心阿尔茨海默病生物标志物与β-淀粉样蛋白 PET 的相关性。
ACS Chem Neurosci. 2022 May 18;13(10):1558-1565. doi: 10.1021/acschemneuro.2c00120. Epub 2022 Apr 27.
9
Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans.基于 Lumipulse 全自动免疫分析的阿尔茨海默病脑脊液生物标志物:与韩国人群中淀粉样蛋白-β PET 和手工免疫分析的一致性:韩国人群中通过 Lumipulse 测量的 CSF AD 生物标志物。
Alzheimers Res Ther. 2021 Jan 12;13(1):22. doi: 10.1186/s13195-020-00767-3.
10
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.阿尔茨海默病连续体中的血浆 Aβ42/40 比值、p-tau181、GFAP 和 NfL:AIBL 队列的横断面和纵向研究。
Alzheimers Dement. 2023 Apr;19(4):1117-1134. doi: 10.1002/alz.12724. Epub 2022 Jul 21.

本文引用的文献

1
Biomarker Changes during 20 Years Preceding Alzheimer's Disease.阿尔茨海默病发病前 20 年的生物标志物变化。
N Engl J Med. 2024 Feb 22;390(8):712-722. doi: 10.1056/NEJMoa2310168.
2
Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer's disease pathology.小胶质细胞激活可防止有潜在阿尔茨海默病病理的非痴呆个体中 tau 聚集物的积累。
Nat Aging. 2022 Dec;2(12):1138-1144. doi: 10.1038/s43587-022-00310-z. Epub 2022 Nov 28.
3
Reflections on our first year.对我们第一年的反思。
Nat Aging. 2022 Jan;2(1):1-2. doi: 10.1038/s43587-022-00169-0.
4
sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer's disease.sTREM2 与阿尔茨海默病中与淀粉样蛋白相关的 p-tau 增加和葡萄糖代谢亢进有关。
EMBO Mol Med. 2023 Feb 8;15(2):e16987. doi: 10.15252/emmm.202216987. Epub 2023 Jan 9.
5
CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study.脑脊液 sTREM2 在神经疾病中的作用:两样本 Mendelian 随机研究。
J Neuroinflammation. 2022 Apr 5;19(1):79. doi: 10.1186/s12974-022-02443-9.
6
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.脑脊液可溶性 TREM2 及其与其他生物标志物和常染色体显性阿尔茨海默病认知的关系:一项纵向观察研究。
Lancet Neurol. 2022 Apr;21(4):329-341. doi: 10.1016/S1474-4422(22)00027-8.
7
Does Soluble TREM2 Protect Against Alzheimer's Disease?可溶性触发受体表达于髓样细胞2(TREM2)能否预防阿尔茨海默病?
Front Aging Neurosci. 2022 Jan 28;13:834697. doi: 10.3389/fnagi.2021.834697. eCollection 2021.
8
Cerebrospinal fluid dynamics and discordant amyloid biomarkers.脑脊液动力学与淀粉样蛋白生物标志物不一致。
Neurobiol Aging. 2022 Feb;110:27-36. doi: 10.1016/j.neurobiolaging.2021.10.017. Epub 2021 Nov 1.
9
Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.小胶质细胞 TREM2 在大脑衰老和阿尔茨海默病中的作用。
Neuroscientist. 2023 Jun;29(3):302-316. doi: 10.1177/10738584211040786. Epub 2021 Sep 2.
10
P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status.脑脊液中P- tau/Aβ42和Aβ42/40的比值对淀粉样蛋白PET状态具有同等的预测价值。
Alzheimers Dement (Amst). 2021 May 18;13(1):e12190. doi: 10.1002/dad2.12190. eCollection 2021.